Viewing Study NCT01054066


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2026-01-02 @ 9:49 AM
Study NCT ID: NCT01054066
Status: COMPLETED
Last Update Posted: 2012-04-12
First Post: 2010-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Managing Chronic Kidney Disease in Eastern North Carolina
Sponsor: East Carolina University
Organization:

Study Overview

Official Title: Management of Chronic Kidney Disease in Eastern North Carolina (MARKER)
Status: COMPLETED
Status Verified Date: 2012-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this program is to educate primary care physicians in four underserved clinics in eastern North Carolina about chronic kidney disease.
Detailed Description: The Division of Nephrology within the Brody School of Medicine recently form a center to focus attention on the needs of patients with kidney disease in eastern North Carolina. It is estimated that more than 40 million Americans have or at risk for CKD. The estimate for CKD in eastern North Carolina is exacerbated by poor access to health care. The mission of the East Carolina University Center for the Study and Treatment of Kidney Disease (ECCKD) is to increase education and awareness, improve treatment and outcomes through research, and better serve patients with CKD in eastern North Carolina.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: